Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ZOARZoar Ltd

NYSE · CIK 0002078148
Filer category<br>Emerging growth company
Entity typeother
SIC2834 Pharmaceutical Preparations
FY end0331
XBRL facts31

Identity from submissions API

NameZoar Ltd
CIK0002078148
TickersZOAR
Exchanges—
Entity typeother
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end0331
State of incorporationE9 Cayman Islands
Phone345-749-8307
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • Dr Ashleys Ltd (2025-09-16T04:00:00.000Z → 2026-03-02T05:00:00.000Z)
Business address
1504 PENINSULA SQ
18 SUNG ON STREET
KOWLOON
00000
Hong Kong
K3
HONG KONG
Mailing address
1504 PENINSULA SQ
18 SUNG ON STREET
KOWLOON
00000
Hong Kong
K3
HONG KONG

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

16 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 6-K 6-K 0001493152-26-053003 001-43544 261568118 34 44400
2026-11-17 CERT NYSE AMERICAN CERTIFICATION 0001143313-26-000057 001-43544 261564932 34 147455
2026-11-17 8-A12B 8-A12B 0001493152-26-052749 001-43544 261564746 34 27082
2026-11-03 425 425 0001493152-26-049726 333-298856 261514630 34 59702
2026-10-26 424B3 424B3 0001493152-26-048567 333-298856 261486548 33 10324140
2026-10-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003333 333-298856 261483357 33 1999
2026-10-22 F-4/A F-4/A 0001493152-26-047960 333-298856 261477051 33 47180027 1 1
2026-10-05 F-4/A F-4/A 0001493152-26-045654 333-298856 261438614 33 21128410 1 1
2026-09-17 425 425 0001493152-26-042978 333-298856 261384749 34 55379
2026-09-15 425 425 0001493152-26-042644 333-298856 261379006 34 68009
2026-09-15 425 425 0001493152-26-042640 333-298856 261378927 34 68964
2026-09-10 F-4 F-4 0001493152-26-042161 333-298856 261371220 33 112755220 1 1
2026-08-18 DRS/A filename1.htm 0001493152-26-038849 377-08465 261288263 33 35940838
2026-06-26 DRS/A filename1.htm 0001493152-26-030355 377-08465 261130672 33 10063063
2026-03-02 DRS/A filename1.htm 0001493152-26-008409 377-08465 26703102 33 10060975
2025-09-16 DRS filename1.htm 0001493152-25-013600 377-08465 251315627 33 9385927

Latest XBRL company facts

One latest value per concept from companyfacts (31 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
ffd NetFeeAmt NetFeeAmt USD 65,114.85 2026-09-10 F-4 2026-09-10 0001493152-26-042161
ffd TtlFeeAmt TtlFeeAmt USD 65,114.85 2026-09-10 F-4 2026-09-10 0001493152-26-042161
ffd TtlOfferingAmt TtlOfferingAmt USD 471.51M 2026-09-10 F-4 2026-09-10 0001493152-26-042161
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-10 F-4 2026-09-10 0001493152-26-042161
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-10 F-4 2026-09-10 0001493152-26-042161
us-gaap Assets Assets USD 23,820 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap Cash Cash USD 23,820 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 23,820 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 23,820 2025-06-06 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 1 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 1 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -88,276 2025-06-06 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -88,276 2025-06-06 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 88,276 2025-06-06 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap Liabilities Liabilities USD 112,096 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 23,820 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 112,096 2025-06-06 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -88,276 2025-06-06 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -88,276 2025-06-06 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap OperatingExpenses Operating Expenses USD 88,276 2025-06-06 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -88,276 2025-06-06 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap OtherLiabilities Other Liabilities USD 112,000 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 112,096 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 112,096 2025-06-06 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -88,276 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -88,276 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1 2025-06-06 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1 2025-06-06 2026-03-31 F-4/A 2026-10-22 0001493152-26-047960

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →